Computed tomography-guided percutaneous microwave ablation with artificial ascites for problematic hepatocellular tumors

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386.
   PubMed Web of Science ®Google Scholar
• El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264–1273. e1261.
   PubMed Web of Science ®Google Scholar
• Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999;229(6):790–799; discussion 799–800.
   PubMed Web of Science ®Google Scholar
• Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35(3):519–524.
   PubMed Web of Science ®Google Scholar
• Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology. 2004;127(5):S248–S260.
   PubMed Web of Science ®Google Scholar
• Vodkin I, Kuo A. Extended criteria donors in liver transplantation. Clin Liver Dis. 2017;21(2):289–301.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Kokudo N, Makuuchi M, et al. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol. 2013;58(4):724–729.
   PubMed Web of Science ®Google Scholar
• Breen DJ, Lencioni R. Image-guided ablation of primary liver and renal tumours. Nat Rev Clin Oncol. 2015;12(3):175–186.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang H, Yang W, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61(5):1579–1590.
   PubMed Web of Science ®Google Scholar
• Lee LH, Hwang JI, Cheng YC, et al. Comparable outcomes of ultrasound versus computed tomography in the guidance of radiofrequency ablation for hepatocellular carcinoma. PLoS One. 2017;12(1):e0169655.
   PubMed Web of Science ®Google Scholar
• Lin SM, Lin CJ, Lin CC, et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut. 2005;54(8):1151–1156.
   PubMed Web of Science ®Google Scholar
• Sala M, Llovet JM, Vilana R, for the Barcelona Cly'nic Liver Cancer (BCLC) Group, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology. 2004;40(6):1352–1360.
   PubMed Web of Science ®Google Scholar
• Lam VW, Ng KK, Chok KS, et al. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol. 2008;15(3):782–790.
   PubMed Web of Science ®Google Scholar
• Chen X, Chen Y, Li Q, et al. Radiofrequency ablation versus surgical resection for intrahepatic hepatocellular carcinoma recurrence: a meta-analysis. J Surg Res. 2015;195(1):166–174.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–451.
   PubMed Web of Science ®Google Scholar
• Yamakado K, Nakatsuka A, Akeboshi M, et al. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol. 2003;14(9):1183–1186.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Yoshida H, Shiina S, et al. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract. Br J Surg. 2006;93(10):1277–1282.
   PubMed Web of Science ®Google Scholar
• Kariya S, Tanigawa N, Kojima H, et al. Radiofrequency ablation combined with CO2 injection for treatment of retroperitoneal tumor: protecting surrounding organs against thermal injury. AJR Am J Roentgenol. 2005;185(4):890–893.
   PubMed Web of Science ®Google Scholar
• Song I, Rhim H, Lim HK, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol. 2009;19(11):2630–2640.
   PubMed Web of Science ®Google Scholar
• Bhagavatula SK, Chick JF, Chauhan NR, et al. Artificial ascites and pneumoperitoneum to facilitate thermal ablation of liver tumors: a pictorial essay. Abdom Radiol. 2017;42(2):620–630.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Rhim H, Lim HK, et al. Effect of artificial ascites on thermal injury to the diaphragm and stomach in radiofrequency ablation of the liver: experimental study with a porcine model. AJR Am J Roentgenol. 2008;190(6):1659–1664.
   PubMed Web of Science ®Google Scholar
• Zhang M, Liang P, Cheng ZG, et al. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. Int J Hyperthermia. 2014;30(2):134–141.
   PubMed Web of Science ®Google Scholar
• Kitchin D, Lubner M, Ziemlewicz T, et al. Microwave ablation of malignant hepatic tumours: intraperitoneal fluid instillation prevents collateral damage and allows more aggressive case selection. Int J Hyperthermia. 2014;30(5):299–305.
   PubMed Web of Science ®Google Scholar
• Hinshaw JL, Laeseke PF, Winter TC, 3rd, et al. Radiofrequency ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decreases postprocedural pain. AJR Am J Roentgenol. 2006;186(5 Suppl):S306–S310.
   PubMed Web of Science ®Google Scholar
• Chen R, Gan Y, Ge N, et al. Transarterial chemoembolization versus radiofrequency ablation for recurrent hepatocellular carcinoma after resection within Barcelona Clinic Liver Cancer Stage 0/A: a retrospective comparative study. J Vasc Interv Radiol. 2016;27(12):1829–1836.
   PubMed Web of Science ®Google Scholar
• Koh PS, Chan AC, Cheung TT, et al. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis. HPB (Oxford). 2016;18(1):72–78.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim JW, Hur YH, et al. Conventional chemoembolization plus radiofrequency ablation versus surgical resection for single, medium-sized hepatocellular carcinoma: propensity-score matching analysis. J Vasc Interv Radiol. 2019;30(3):284–292. e281.
   PubMed Web of Science ®Google Scholar
• Li B, Liu C, Xu XX, et al. Clinical application of artificial ascites in assisting CT-guided percutaneous cryoablation of hepatic tumors adjacent to the gastrointestinal tract. Sci Rep. 2017;7(1):16689.
   PubMed Web of Science ®Google Scholar
• Dunne RM, Shyn PB, Sung JC, et al. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: a comparison of the safety of cryoablation and radiofrequency ablation. Eur J Radiol. 2014;83(4):632–638.
   PubMed Web of Science ®Google Scholar
• Wright AS, Sampson LA, Warner TF, et al. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236(1):132–139.
   PubMed Web of Science ®Google Scholar
• Andreano A, Huang Y, Meloni MF, et al. Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue. Med Phys. 2010;37(6 Part 1):2967–2973.
   PubMed Web of Science ®Google Scholar
• Qian GJ, Wang N, Shen Q, et al. Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: experimental and clinical studies. Eur Radiol. 2012;22(9):1983–1990.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Meloni F, Solbiati L, For the Collaborative Italian Group using AMICA system, et al. Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol. 2012;35(4):868–874.
   PubMed Web of Science ®Google Scholar
• Liang P, Yu J, Yu XL, et al. Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut. 2012;61(7):1100–1101.
   PubMed Web of Science ®Google Scholar
• van Tilborg AA, Scheffer HJ, de Jong MC, et al. MWA versus RFA for perivascular and peribiliary CRLM: a retrospective patient- and lesion-based analysis of two historical cohorts. Cardiovasc Intervent Radiol. 2016;39(10):1438–1446.
   PubMed Web of Science ®Google Scholar
• Uehara T, Hirooka M, Ishida K, et al. Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. J Gastroenterol. 2007;42(4):306–311.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, for the International Working Group on Image-guided Tumor Ablation, Interventional Oncology Sans Frontières Expert Panel, Technology Assessment Committee of the Society of Interventional Radiology, and the Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. Radiology. 2014;273(1):241–260.
   PubMed Web of Science ®Google Scholar
• Khalilzadeh O, Baerlocher MO, Shyn PB, et al. Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol. 2017;28(10):1432–1437. e1433.
   PubMed Web of Science ®Google Scholar
• Koda M, Tokunaga S, Miyoshi K, et al. Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression. J Gastroenterol. 2013;48(11):1283–1292.
   PubMed Web of Science ®Google Scholar
• Kim YS, Rhim H, Cho OK, et al. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol. 2006;59(3):432–441.
   PubMed Web of Science ®Google Scholar
• Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol. 2003;38(10):977–981.
   PubMed Web of Science ®Google Scholar
• Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97(5):1253–1262.
   PubMed Web of Science ®Google Scholar
• Shibata T, Isoda H, Hirokawa Y, et al. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology. 2009;252(3):905–913.
   PubMed Web of Science ®Google Scholar
• Kim JW, Kim JH, Won HJ, et al. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol. 2012;81(3):e189–193.
   PubMed Web of Science ®Google Scholar
• Liu SR, Liang P, Yu XL, et al. Percutaneous microwave ablation for liver tumours adjacent to the marginal angle. Int J Hyperthermia. 2014;30(5):306–311.
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y, Yu X, et al. Malignant liver tumors: treatment with percutaneous microwave ablation–complications among cohort of 1136 patients. Radiology. 2009;251(3):933–940.
   PubMed Web of Science ®Google Scholar